Fleury SA operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other
pharmaceutical manufacturers in Latin America:
sales of 3.29 billion Brazilian Reals [US$1.05 billion]
Genomma Lab Internacional Sab De Cv
(11.32 billion Mexican Pesos [US$640.84 million]
of which 59%
was International), and
Diagnosticos Da America SA
(3.04 billion Brazilian Reals [US$967.79 million]
of which 100%
was servi os auxiliares).
During the year ended December of 2016, sales at
Fleury SA were 2.10 billion Brazilian Reals (US$667.13 million).
increase of 10.6%
versus 2015, when the company's sales were 1.89 billion Brazilian Reals.
This was the fifth consecutive year of sales increases at Fleury SA
(and since 2011, sales have increased a total of 86%).
Sales of Integrated Medicine saw an increase
12.3% in 2016, from
309.42 million Brazilian Reals to 347.55 million Brazilian Reals.